Authors:
CURRIE JL
BLESSING JA
MUSS HB
FOWLER J
BERMAN M
BURKE TW
Citation: Jl. Currie et al., COMBINATION CHEMOTHERAPY WITH HYDROXYUREA, DACARBAZINE (DTIC), AND ETOPOSIDE IN THE TREATMENT OF UTERINE LEIOMYOSARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 61(1), 1996, pp. 27-30
Authors:
CURRIE JL
BLESSING JA
MCGEHEE R
SOPER JT
BERMAN M
Citation: Jl. Currie et al., PHASE-II TRIAL OF HYDROXYUREA, DACARBAZINE (DTIC), AND ETOPOSIDE (VP-16) IN MIXED MESODERMAL TUMORS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 61(1), 1996, pp. 94-96
Authors:
SUTTON G
BLESSING JA
PARK R
DISAIA PJ
ROSENSHEIN N
Citation: G. Sutton et al., IFOSFAMIDE TREATMENT OF RECURRENT OR METASTATIC ENDOMETRIAL STROMAL SARCOMAS PREVIOUSLY UNEXPOSED TO CHEMOTHERAPY - A STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP, Obstetrics and gynecology, 87(5), 1996, pp. 747-750
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF GALLIUM NITRATE (NSC NUMBER-15200) IN NONSQUAMOUSCELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(6), 1995, pp. 495-497
Citation: R. Asbury et al., AMINOTHIADIAZOLE IN THE TREATMENT OF ADVANCED LEIOMYOSARCOMA OF THE UTERINE CORPUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(5), 1995, pp. 397-399
Citation: A. Manetta et al., A PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH ADVANCEDSQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(5), 1995, pp. 439-440
Citation: Ky. Look et al., A PHASE-II TRIAL OF MERBARONE (NSC-336628) AS SALVAGE THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(5), 1995, pp. 441-443
Citation: A. Manetta et al., PHASE-II STUDY OF FAZARABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER- A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(2), 1995, pp. 156-157
Citation: Ky. Look et al., A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN RECURRENT EPITHELIAL OVARIAN-CARCINOMA, American journal of clinical oncology, 18(1), 1995, pp. 19-22
Authors:
THIGPEN T
BLESSING JA
GALLUP DG
MAIMAN M
SOPER JT
Citation: T. Thigpen et al., PHASE-II TRIAL OF MITOMYCIN-C IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 57(3), 1995, pp. 376-379
Authors:
BRALY PS
BEREK JS
BLESSING JA
HOMESLEY HD
AVERETTE H
Citation: Ps. Braly et al., INTRAPERITONEAL ADMINISTRATION OF CISPLATIN AND 5-FLUOROURACIL IN RESIDUAL OVARIAN-CANCER - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP TRIAL, Gynecologic oncology, 56(2), 1995, pp. 164-168
Authors:
THIGPEN JT
BLESSING JA
BALL H
HUMMEL SJ
BARRETT RJ
Citation: Jt. Thigpen et al., PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH PROGRESSIVE OVARIAN-CARCINOMA AFTER PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1748-1753
Authors:
THIGPEN JT
BLESSING JA
DISAIA PJ
YORDAN E
CARSON LF
EVERS C
Citation: Jt. Thigpen et al., A RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(7), 1994, pp. 1408-1414
Authors:
WILLIAMS S
BLESSING JA
LIAO SY
BALL H
HANJANI P
Citation: S. Williams et al., ADJUVANT THERAPY OF OVARIAN GERM-CELL TUMORS WITH CISPLATIN, ETOPOSIDE, AND BLEOMYCIN - A TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP, Journal of clinical oncology, 12(4), 1994, pp. 701-706
Citation: Rf. Asbury et al., A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (SC NUMBER-308847) IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX, American journal of clinical oncology, 17(2), 1994, pp. 125-128
Authors:
SUTTON GP
BLESSING JA
HOMESLEY HD
MALFETANO JH
Citation: Gp. Sutton et al., A PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED ORRECURRENT MIXED MESODERMAL TUMORS OF THE OVARY PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 53(1), 1994, pp. 24-26
Authors:
WILLIAMS SD
BLESSING JA
DISAIA PJ
MAJOR FJ
BALL HG
LIAO SY
Citation: Sd. Williams et al., 2ND-LOOK LAPAROTOMY IN OVARIAN GERM-CELL TUMORS - THE GYNECOLOGIC-ONCOLOGY-GROUP EXPERIENCE, Gynecologic oncology, 52(3), 1994, pp. 287-291
Authors:
SUTTON GP
BLESSING JA
BARRETT RJ
GALLUP DG
Citation: Gp. Sutton et al., PHASE-II TRIAL OF MENOGARIL IN PATIENTS WITH SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 52(2), 1994, pp. 229-231
Citation: Fb. Stehman et al., QUALITY ASSESSMENT AND ASSURANCE PROGRAMS IN THE GYNECOLOGIC-ONCOLOGY-GROUP, Obstetrics and gynecology, 84(6), 1994, pp. 1059-1062
Authors:
SUTTON GP
BLESSING JA
HOMESLEY HD
MCGUIRE WP
ADCOCK L
Citation: Gp. Sutton et al., PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN REFRACTORY ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Cancer, 73(5), 1994, pp. 1453-1455
Citation: Hb. Muss et al., ECHINOMYCIN IN RECURRENT AND METASTATIC ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP, American journal of clinical oncology, 16(6), 1993, pp. 492-493
Authors:
BARRETT RJ
BLESSING JA
HOMESLEY HD
TWIGGS L
WEBSTER KD
Citation: Rj. Barrett et al., CIRCADIAN-TIMED COMBINATION DOXORUBICIN-CISPLATIN CHEMOTHERAPY FOR ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP, American journal of clinical oncology, 16(6), 1993, pp. 494-496
Citation: Lg. Feun et al., A PHASE-II TRIAL OF TRICYCLIC NUCLEOSIDE PHOSPHATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 16(6), 1993, pp. 506-508
Authors:
ASBURY RF
BLESSING JA
LOOK KY
CLARKEPEARSON D
HOMESLEY HD
Citation: Rf. Asbury et al., A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 16(6), 1993, pp. 529-531
Citation: M. Markman et al., SALVAGE INTRAPERITONEAL THERAPY OF OVARIAN-CANCER EMPLOYING CISPLATINAND ETOPOSIDE - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 50(2), 1993, pp. 191-195